Abstract:BACKGROUND With advancements in the development of endoscopic technologies, the endoscopic submucosal dissection (ESD) has been one of the gold-standard therapies for early gastric cancer. AIM To investigate the efficacy and safety ESD in the treatment of early gastric cancer and precancerous lesions in the elderly patients. METHODS Seventy-eight elderly patients with early gastric cancer and precancerous lesions admitted to the Third Affiliated Hospital of Qiqihar Medical University were selected and classified into two groups according to the different surgical therapies they received between January 2021 and June 2022. Among them, 39 patients treated with ESD were included in an experimental group, and 39 patients treated with endoscopic mucosal resection (EMR) were included in a control group. We compared the basic intraoperative conditions, postoperative short-term recovery, long-term recovery effects and functional status of gastric mucosa between the two groups; the basic intraoperative conditions included lesion resection, intraoperative bleeding and operation time; the postoperative short-term recovery assessment indexes were length of hospital stay and incidence of surgical complications; and the long-term recovery assessment indexes were the recurrence rate at 1 year postoperatively and the survival situation at 1 year and 3 years postoperatively; and we compared the preoperative and predischarge serum pepsinogen I (PG I) and PG II levels and PG I/PG II ratio in the two groups before surgery and discharge. RESULTS The curative resection rate and the rate of en bloc resection were higher in the experimental group than in the control group. The intraoperative bleeding volume was higher in the experimental group than in the control group. The operation time was longer in the experimental group than that in the control group, and the rate for base residual focus was lower in the experimental group than that of the control group, and the differences were all statistically significant (all P < 0.05). The length of hospital stay was longer in the experimental group than in the control group, and the incidence of surgical complications, 1-year postoperative recurrence rate and 3-year postoperative survival rate were lower in the experimental group than in the control group, and the differences were statistically significant (all P 0.05). Before discharge, PG I and PG I/PG II ratio were elevated in both groups compared with the preoperative period, and the above indexes were higher in the experimental group than those in the control group, and the differences were statistically significant (both P < 0.05). Moreover, before discharge, PG II level was lower in both groups compared with the preoperative period, and the level was lower in the experimental group than in the control group, and the differences were all statistically significant (all P < 0.05). CONCLUSION Compared with EMR, ESD surgery is more thorough. It reduces the rate of base residual focus, recurrence rate, surgical complications, and promotes the recovery of gastric cells and glandular function. It is safe and suitable for clinical application.

Development in the endoscopic treatment of early gastric cancer

Comparison of endoscopic resection and gastrectomy for the treatment of early gastric cancer: a meta-analysis

Indication and evaluation of endoscopic submucosa dissection in the treatment of early gastric cancer

Sa1585 Long-Term Clinical Evaluation of Endoscopic Submucosal Dissection for Early Gastric Neoplasms

Treatment of early gastroesophageal cancer and precancerous lesion with endoscopic mucosal resection

Present situation of minimally invasive surgical treatment for early gastric cancer

[Application of Endoscopic Submucosal Dissection in Treatment of Early Gastric Cancer].

Clinical Outcomes of Endoscopic Submucosal Dissection for Early Gastric Cancer in Different Indications

Endoscopic treatment of early adenocarcinoma of the esophagogastric junction

Exploring non-curative endoscopic submucosal dissection: Current treatment optimization and future indication expansion

Effect of endoscopic submucosal dissection on gastrointestinal function and nutritional status in patients with early gastric cancer

Endoscopic ultrasonography in the treatment of early upper gastrointestinal cancer

A Recent Argument for the Use of Endoscopic Submucosal Dissection for Early Gastric Cancers

Current status of endoscopic resection in China.

Long-term outcomes of endoscopic treatment of early gastric cancer in elderly patients

Endoscopic submucosal dissection for early gastric cancer: It is time to consider the quality of its outcomes

[Application Endoscopic Mucosal Resection to Therapy Early Gastrointestinal Cancer and Precancerous Lesion].

A Retrospective Study of Endoscopic Treatment on Early Gastric Cancer in a Single Center for 10 Years

Advanced Diagnostic and Therapeutic Endoscopy for Early Gastric Cancer

Efficacy and safety of endoscopic submucosal dissection for early gastric cancer and precancerous lesions in elderly patients

Treatment of early esophageal cancer with endoscopic mucosal resection using a ligation device